Sign in
4/A

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-19-035849

Options or other derivatives

  • Senior Vice President and CFO acquired 127,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

STAAB THOMAS R II · Senior Vice President and CFO

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2019-12-17 Grant or award : show line 1 in the form Emp. Stock Option (Right to Buy) +127,000 127,000 D
Loading xslF345X03/form4a.xml…